Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.
Open | $4.040 |
Close | $4.130 |
Volume / Avg. | 5.953K / 17.887K |
Day Range | 4.040 - 4.286 |
52 Wk Range | 1.160 - 9.680 |
Market Cap | $36.813M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 1% |
Days to Cover | 2.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Marker Therapeutics (NASDAQ: MRKR) through any online brokerage.
Other companies in Marker Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for Marker Therapeutics (NASDAQ: MRKR) was reported by Ladenburg Thalmann on Tuesday, April 30, 2024. The analyst firm set a price target for 11.00 expecting MRKR to rise to within 12 months (a possible 174.31% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $4.01 last updated Today at May 10, 2024 at 7:11 AM EDT.
There are no upcoming dividends for Marker Therapeutics.
Marker Therapeutics’s Q4 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Marker Therapeutics.
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.